Lyme Disease Vaccine Uses mRNA to Encode Tick Saliva Proteins – Genetic Engineering & Biotechnology News

A new Lyme vaccine candidate not only leverages a new modalitymRNAit also takes aim at some new targetstick saliva proteins. mRNA vaccines have already become familiar because of the success of mRNA-based COVID-19 vaccines. However, tick saliva proteins…

Click here to view the original article.